Tuesday, February 14, 2012 11:10:11 PM
MMRF .038 MMRGlobal, Inc. (Patent owning company. Possible Merger and Aquisition target)
Market Value1 $12,610,732 a/o Feb 13, 2012
Shares Outstanding 336,286,196 a/o Oct 17, 2011
Float Not Available
Authorized Shares 650,000,000
MMRGlobal Receives Valentines Valued at More Than $100 Million
MMRGlobal, Inc. (OTCBB: MMRF) ("MMR"), a leading provider of Personal Health Records ("PHR"), MyEsafeDepositBox storage solutions and electronic document management and imaging systems for healthcare professionals, announced that the United States Patent and Trademark Office has scheduled the issuance of two U.S. patents today. U.S. Patent No. 8,117,045 is entitled "Method and System for Providing Online Medical Records." U.S. Patent No. 8,117,646 is entitled "Method and System for Providing Online Records." The issuance of these patents further expands the protection on the Company's technology related to online Personal Health Records and document imaging and filing solutions. The patented methods are embodied by the Company's solutions, including the storage, management of, and emergency access to health records and other important documents including dental records, children's health records, and veterinary health records for pets.
According to a report issued by The MichaelBass Group, an investment banking and strategic advisory services firm focused on health IT, the patents owned by MyMedicalRecords, Inc., the Company's wholly owned-subsidiary, are valued at $300 million to as much as $800 million. "We believe the issuance of these patents could represent significant value to the Company's shareholders just one week in advance of HIMSS 2012, the largest and most important health IT conference and exhibition in the world, where we will showcase our MMRPro and MyMedicalRecords Personal Health Record products and services." said Robert H. Lorsch, MMRGlobal Chairman and CEO. "We believe our portfolio of health IT patents will continue to grow in value, especially given the national mandate that Americans have access to an electronic Personal Health Record by 2014 under the HITECH Act. We are encouraged by the fact that both our health IT and biotech intellectual property rights are already the subject of substantial license agreements."
The Jan 20, 2012 report from MichaelBass, which can be viewed online at http://michaelbass.com/PDF/JAN20MMRF.pdf, cites the market for Personal Health Records at $19 billion and focuses on the patents issued and pending in connection with a "Method and System for Providing Online Medical Records" and a "Method and System for Providing Online Records." The patents cover numerous claims involving the provision of Personal Health Records and other health information and document management systems and technologies. The patents also address the management of paper and other information contained in a Personal Health Record and deal with the fact that while doctors are migrating to Electronic Medical Records, the average physician still receives an average of 1,033 faxes per month of patient information.
The Company's growing portfolio of health IT patents includes those already issued to MMR in Australia and Singapore and others pending in countries around the world. These patents and other pending patent applications will be utilized in the Company's suite of Personal Health Record, professional document management and imaging systems and MyESafeDepositBox (www.myesafevideos.com) products and services. The Company also plans on offering Personal Pet Records through Dancing Paws (www.dancingpaws.com), a company founded by MMR CEO Robert H. Lorsch.
MMRGlobal also owns a significant portfolio of biotech assets which were acquired as a result of its reverse merger with Favrille, Inc., a San Diego biotech company, in January 2009. The Company spent more than $140 million on the development of a portfolio of biotech assets and related patents including the FavId® idiotype vaccine that was the Company's lead product candidate for the treatment of B-cell Non-Hodgkin's Lymphoma and also panels of anti-CD20 antibodies. Over the last several years, MMR has been working to maximize the value of both its health IT and biotech intellectual property portfolios which are already the subject of substantial license agreements.
MMRF - Daily Candlesticks
Market Value1 $12,610,732 a/o Feb 13, 2012
Shares Outstanding 336,286,196 a/o Oct 17, 2011
Float Not Available
Authorized Shares 650,000,000
MMRGlobal Receives Valentines Valued at More Than $100 Million
MMRGlobal, Inc. (OTCBB: MMRF) ("MMR"), a leading provider of Personal Health Records ("PHR"), MyEsafeDepositBox storage solutions and electronic document management and imaging systems for healthcare professionals, announced that the United States Patent and Trademark Office has scheduled the issuance of two U.S. patents today. U.S. Patent No. 8,117,045 is entitled "Method and System for Providing Online Medical Records." U.S. Patent No. 8,117,646 is entitled "Method and System for Providing Online Records." The issuance of these patents further expands the protection on the Company's technology related to online Personal Health Records and document imaging and filing solutions. The patented methods are embodied by the Company's solutions, including the storage, management of, and emergency access to health records and other important documents including dental records, children's health records, and veterinary health records for pets.
According to a report issued by The MichaelBass Group, an investment banking and strategic advisory services firm focused on health IT, the patents owned by MyMedicalRecords, Inc., the Company's wholly owned-subsidiary, are valued at $300 million to as much as $800 million. "We believe the issuance of these patents could represent significant value to the Company's shareholders just one week in advance of HIMSS 2012, the largest and most important health IT conference and exhibition in the world, where we will showcase our MMRPro and MyMedicalRecords Personal Health Record products and services." said Robert H. Lorsch, MMRGlobal Chairman and CEO. "We believe our portfolio of health IT patents will continue to grow in value, especially given the national mandate that Americans have access to an electronic Personal Health Record by 2014 under the HITECH Act. We are encouraged by the fact that both our health IT and biotech intellectual property rights are already the subject of substantial license agreements."
The Jan 20, 2012 report from MichaelBass, which can be viewed online at http://michaelbass.com/PDF/JAN20MMRF.pdf, cites the market for Personal Health Records at $19 billion and focuses on the patents issued and pending in connection with a "Method and System for Providing Online Medical Records" and a "Method and System for Providing Online Records." The patents cover numerous claims involving the provision of Personal Health Records and other health information and document management systems and technologies. The patents also address the management of paper and other information contained in a Personal Health Record and deal with the fact that while doctors are migrating to Electronic Medical Records, the average physician still receives an average of 1,033 faxes per month of patient information.
The Company's growing portfolio of health IT patents includes those already issued to MMR in Australia and Singapore and others pending in countries around the world. These patents and other pending patent applications will be utilized in the Company's suite of Personal Health Record, professional document management and imaging systems and MyESafeDepositBox (www.myesafevideos.com) products and services. The Company also plans on offering Personal Pet Records through Dancing Paws (www.dancingpaws.com), a company founded by MMR CEO Robert H. Lorsch.
MMRGlobal also owns a significant portfolio of biotech assets which were acquired as a result of its reverse merger with Favrille, Inc., a San Diego biotech company, in January 2009. The Company spent more than $140 million on the development of a portfolio of biotech assets and related patents including the FavId® idiotype vaccine that was the Company's lead product candidate for the treatment of B-cell Non-Hodgkin's Lymphoma and also panels of anti-CD20 antibodies. Over the last several years, MMR has been working to maximize the value of both its health IT and biotech intellectual property portfolios which are already the subject of substantial license agreements.
MMRF - Daily Candlesticks
"I got a fever, and the only cure is, more cowbell, so send in the bulls!"
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
